Takumi Tanikawa

Mr. Takumi Tanikawa

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
STShintaro Tsuji
Shintaro Tsuji
ITIshikawa Tomoki
Ishikawa Tomoki
YMYasuhiro Morii
Yasuhiro Morii
HZHongjian Zhang
Hongjian Zhang
TSTeppei Suzuki
Teppei Suzuki
KOKatsuhiko Ogasawara
Katsuhiko Ogasawara
Background: Apps for real-time continuous glucose monitoring (CGM) on smartphones and other devices linked to CGM systems have recently been developed, and such CGM apps are also coming into use in Japan. In comparison with conventional retrospective CGM, the use of CGM apps improves patients’ own blood glucose control, which is expected to help slow the progression of type 2 diabetes mellitus (DM) and prevent complications, but the effect of their introduction on medical costs remains unknown. Objective: Our objective in this study was to perform an economic appraisal of CGM apps from the viewpoint of assessing public medical costs associated with type 2 DM, using the probability of developing type 2 DM–associated complications, and data on medical costs and utility value to carry out a medical cost simulation using a Markov model in order to ascertain the cost-effectiveness of the apps. Methods: We developed a Markov model with the transition states of insulin therapy, nephrosis, dialysis, and cardiovascular disease, all of which have a major effect on medical costs, to identify changes in medical costs and utility values resulting from the introduction of a CGM app and calculated the incremental cost-effectiveness ratio (ICER). Results: The ICER for CGM app use was US $33,039/quality-adjusted life year (QALY). Conclusions: Sensitivity analyses showed that, with the exception of conditions where the transition probability of insulin therapy, utility value, or increased medical costs increases, the ICER for the introduction of CGM apps was below the threshold of US $43,478/QALY used by the Central Social Insurance Medical Council. Our results provide basic data on the cost-effectiveness of introducing CGM apps, which are currently starting to come into use.

8 November 2019 in BMC Urology
Verified
Journal Article
Open access
PDF file
YMYasuhiro Morii
Yasuhiro Morii
TOTakahiro Osawa
Takahiro Osawa
TSTeppei Suzuki
Teppei Suzuki
NSNobuo Shinohara
Nobuo Shinohara
THToru Harabayashi
Toru Harabayashi
KOKatsuhiko Ogasawara
Katsuhiko Ogasawara
Background: Robot-assisted radical cystectomy is becoming a common treatment for bladder carcinoma. However, in comparison with open radical cystectomy, its cost-effectiveness has not been confirmed. Although few published reviews have compared total costs between the two surgical procedures, no study has compared segmental costs and explained their impact on total costs. Methods: A systematic review was conducted based on studies on the segmental costs of open, laparoscopic, and robot-assisted radical cystectomy using PubMed, Web of Science, and Cochrane Library databases to provide insight into cost-effective management methods for radical cystectomy. The segmental costs included operating, robot-related, complication, and length of stay costs. A sensitivity analysis was conducted to determine the impact of the annual number of cases on the per-case robot-related costs. Results: We identified two studies that compared open and laparoscopic surgeries and nine that compared open and robotic surgeries. Open radical cystectomy costs were higher than those of robotic surgeries in two retrospective single-institution studies, while robot-assisted radical cystectomy costs were higher in 1 retrospective single-institution study, 1 randomized controlled trial, and 4 large database studies. Operating costs were higher for robotic surgery, and accounted for 63.1–70.5% of the total robotic surgery cost. Sensitivity analysis revealed that robot-related costs were not a large proportion of total surgery costs in institutions with a large number of cases but accounted for a large proportion of total costs in centers with a small number of cases. Conclusions: The results show that robot-assisted radical cystectomy is more expensive than open radical cystectomy. The most effective methods to decrease costs associated with robotic surgery include a decrease in operating time and an increase in the number of cases. Further research is required on the cost-effectiveness of surgeries, including quality measures such as quality of life and quality-adjusted life years.

1 January 2018 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
KFKensuke Fujiwara
Kensuke Fujiwara
TOToshiya Osanai
Toshiya Osanai
EKEiichi Kobayashi
Eiichi Kobayashi
TTTakumi Tanikawa
Takumi Tanikawa
KKKen Kazumata
Ken Kazumata
KOKatsuhiko Ogasawara
Katsuhiko Ogasawara

1 May 2021 in Telemedicine and e-Health
Verified
Journal Article
Closed access
HSHiroki Shimizu
Hiroki Shimizu
TTTakumi Tanikawa
Takumi Tanikawa
HMHiro Mizuguchi
Hiro Mizuguchi
YTYuji Tani
Yuji Tani
KOKatsuhiko Ogasawara
Katsuhiko Ogasawara
Background: Telemedicine is not significantly spreading globally and large variations in its availability and use exist internationally. Although many factors already inhibit the dissemination of telemedicine, its complexly intertwined factors make it more difficult to solve this problem. This study aimed to analyze and visualize relationships among factors inhibiting the dissemination of telemedicine. We applied the interpretive structural modeling method and cross-impact matrix multiplication applied to classification analysis. Materials and Methods: Factors inhibiting the dissemination of telemedicine in Japan were extracted by literature review and hearing from four medical informatics experts belonging to a university or hospital using the Kawakita Jiro method. Results: Eighteen factors were extracted as those inhibiting the dissemination of telemedicine service in Japan: initial and operation cost, research data, legal development, profitability, usability, human resources, image quality, network speed, information security, technical limitation, restriction for clinical practice, practice continuity, target use case, burden for physicians, respondence, risks for clinical safety, understanding of medical staff, and understanding of patients. The hierarchical structure chart showed a nine-level structure and the cross-impact matrix showed the relationship among factors and the classification of them inhibiting the dissemination of telemedicine. Discussion: We found that the underlying factors were high implementation and operation costs, low research data, and risks for clinical safety. Implementation and operation costs, research data, legal development, and profitability have high driving power; thus, it is expected that the elimination of these inhibiting factors would lead to the dissemination of telemedicine. Conclusions: There are many kinds of factors inhibiting the dissemination of telemedicine in Japan. The result of this showed the structure of these factors visually and could be useful to solve the problem inhibiting the dissemination of telemedicine effectively and efficiently.

1 January 2012 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
TTTakumi Tanikawa
Takumi Tanikawa
HOHisateru Ohba
Hisateru Ohba
KOKatsuhiko Ogasawara
Katsuhiko Ogasawara
YOYasuo Okuda
Yasuo Okuda
YAYusuke Ando
Yusuke Ando
This is a pilot study that aims to elucidate regional disparities in the distribution of medical resources in Japan. For this purpose, we employed th

1 August 2019 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
YMYasuhiro Morii
Yasuhiro Morii
TOToshiya Osanai
Toshiya Osanai
TITomoki Ishikawa
Tomoki Ishikawa
KFKensuke Fujiwara
Kensuke Fujiwara
TTTakumi Tanikawa
Takumi Tanikawa
KOKatsuhiko Ogasawara
Katsuhiko Ogasawara